Skip to main content
Daily market wrap · Thursday, 23 July 2026
~2 min read

Nifty slips below 200-DMA as breadth collapses — not a dip

Net new highs just turned negative, decliners beat advancers 2-to-1, and the Stage-2 cohort keeps shrinking.
Stage2Stocks Market Desk
Nifty 50
23,870
-0.5% on the day
Regime
Transition
1th day · neutral-to-down
Breadth
41%
above 200-DMA · narrow
Adv / Dec
674 / 1,535
decliners ahead
52w highs / lows
110 / 123
net -13
Stage-2 share
33%
cohort narrowing

The tape is hollowing out, not pulling back inside strength. Today's -0.5% on Nifty 50 to 23,869.6 is the fifth losing or flat session in six, and the internals underneath are deteriorating faster than the index suggests — this is a broad decline, not a dip to buy. The regime has tipped to transition with a neutral-to-down near-term read, and the weight of evidence says risk is building.

Trajectory: the internals are getting worse, not stabilising

The slow structural gauge — the share of stocks above their 200-day average — has slid from 43.8% on 16 July to 41.4% today, a steady erosion that confirms distribution is not confined to a few names. The fast short-term gauge, stocks above their 20-day average, has collapsed from 43.5% to 31.1% over the same six sessions, and today's advance-decline of 1,535 decliners to 674 advancers is the second consecutive session of roughly 2-to-1 selling pressure. The clincher: net new 52-week highs just turned negative at -13, the first negative print in this sequence, meaning more stocks are making fresh lows than fresh highs. Over the last five days, 64 stocks degraded from Stage 2 to Stage 3 against only 36 moving the other way — a net loss of 28 from the advancing cohort — and the Stage-2 share has narrowed for five straight sessions to 33.1%.

Leadership: IT and Health Care holding, but the bench is thin

Information Technology was the only sector to close in the green today, up a marginal 0.2%, and it is where the Stage-2 cohort is expanding fastest over the last 20 days, alongside Health Care — the three-month leader at +15.8% — where RPG Life Sciences cleared the screen with a high setup score. Real Estate leads on the one-month table at +8.7% and its Stage-2 cohort is also widening, but one day's relative resilience in IT does not make a healthy market when decliners are running at more than double advancers. The setups the screen surfaces today are real — Kapston Services and Kabra Extrusion Technik in Industrials sit at the top — but in a tape where new lows are outpacing new highs and the advancing cohort is contracting, the historical follow-through rate on even clean setups deteriorates materially.

Leading Stage-2 setups
StockSectorSetup% 1D
Kabra Extrusion Technik LtdIndustrials9.4
Kapston Services LtdIndustrials9.4
Tirupati Forge LtdConsumer Discretionary9.2
RPG Life Sciences LtdHealth Care9.0
Bharat Seats LtdConsumer Discretionary9.0
India Nippon Electricals LtdConsumer Discretionary9.0
Filatex India LtdConsumer Discretionary9.0
Muthoot Microfin LtdFinancials9.0
Sector performance — cap-weighted, ranked by today’s move
Sector1D1M3MRSStage 2
Information Technology+0.2%+4.2%-3.2%4231%
Consumer Discretionary-0.1%+2.6%+4.0%6835%
Health Care-0.5%+2.9%+15.8%7350%
Materials-0.7%+0.1%+0.5%6931%
Consumer Staples-0.7%+0.1%-3.2%5426%
Communication Services-0.8%+2.0%+9.1%6616%
Financials-0.8%-0.5%-3.3%6134%
Energy-1.0%-0.3%-3.5%5629%
Industrials-1.1%-3.1%+6.4%6937%
Utilities-1.3%-3.5%-1.2%6320%
Real Estate-1.4%+8.7%+10.1%5022%
Breadth note
110 stocks are at or near new 52-week highs today — broad participation.
Work the same data live: open the full stock screener, watch the live market dashboard, or check the market-timing regime read. New to the method? Start with the four stages.

Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.

More market wraps